SCARBOROUGH, Maine — To help prepare communities ahead of peak flu season, Hannaford is now offering flu shots at its in-store pharmacies in M…
From
To
GoodRx reports a summer spike in demand for epinephrine auto-injectors as students prepare for school, worsening current shortages.
GoodRx reports over 80% of U.S. counties lack healthcare access, affecting 120 million people amid ongoing pharmacy closures and healthcare deserts.
GoodRx reports that in 2025, novel drug and biosimilar approvals lag slightly behind last year, while first generic approvals are ahead.
GoodRx reports on identifying real Wegovy pens, which come in five colors and lack dose selectors. Counterfeits pose health risks; buy from trusted sources.
GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain FDA approval by 2026.
GoodRx reveals just how inadequate and restrictive prescription insurance coverage has become.
GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make the process of switching from a compounded GLP-1 to a brand-name GLP-1 smoother, safer, and more affordable.
SaveHealth explores how consumers are leveraging discount card platforms to save money while working with or around their insurance coverage.
(The Center Square) – More than two years after the pandemic ended, New Hampshire lawmakers are pushing a controversial plan that would authorize pharmacists to dispense the drug ivermectin to treat COVID-19 without a prescription.